Despite these concerns, several studies have demonstrated the beneficial outcomes associated with cholinesterase inhibitor use, including slower cognitive decline41, reduced stroke risk42, and lower all-cause mortality among patients with AD who have histories of myocardial infarction43. The gene discussed is BCHE; the disease is Stroke.